Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Sep;17(9):577-579.
doi: 10.1200/OP.21.00524. Epub 2021 Aug 11.

Taking Tele Behind the Scenes: Remote Clinical Trial Monitoring Comes of Age During the COVID-19 Pandemic

Erin L Williams  1 , Desiree L Pierre  1 , Mary E Martin  1 , Muhammad S Beg  1   2 , David E Gerber  1   2   3
Affiliations
Editorial

Taking Tele Behind the Scenes: Remote Clinical Trial Monitoring Comes of Age During the COVID-19 Pandemic

Erin L Williams et al. JCO Oncol Pract. 2021 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Erin L. WilliamsConsulting or Advisory Role: Lilly, Genentech Muhammad S. BegConsulting or Advisory Role: Ipsen, Array BioPharma, AstraZeneca/MedImmune, Cancer Commons, Legend Biotech, Foundation MedicineResearch Funding: Celgene, Bristol Myers Squibb, AstraZeneca/MedImmune, Merck Serono, Agios, Five Prime Therapeutics, MedImmune, ArQule, Genentech, Sillajen, CASI Pharmaceuticals, ImmuneSensor Therapeutics, Tolero Pharmaceuticals David E. GerberStock and Other Ownership Interests: Gilead SciencesConsulting or Advisory Role: Samsung Bioepis, Catalyst Pharmaceuticals, Mirati Therapeutics, Janssen Oncology, BeiGeneResearch Funding: BerGenBio, Karyopharm Therapeutics, AstraZenecaPatents, Royalties, Other Intellectual Property: Royalties from Oxford University Press from two books, Royalties from Decision Support in Medicine from the Clinical Decision Support—Oncology on-line program, Patent pending: “Prediction and Treatment of Immunotherapeutic Toxicity” (provisional, application number 62/461,455)Uncompensated Relationships: Bristol Myers SquibbNo other potential conflicts of interest were reported.

Comment in

References

    1. Darcourt JG, Aparicio K, Dorsey PM, et al. : Analysis of the implementation of telehealth visits for care of patients with cancer in houston during the COVID-19 pandemic. JCO Oncol Pract 17:e36-e43, 2021 - PMC - PubMed
    1. Henry J, Pylypchuk Y, Searcy T, et al. : Adoption of Electronic Health Record Systems Among U.S. Non-federal Acute Care Hospitals: 2008-2015. ONC Data Brief, No. 35. Washington, DC, Office of the National Coordinator for Health Information Technology, 2016
    1. US Food and Drug Administration : Oversight of Clinical Investigations—A Risk-Based Approach to Monitoring: Guidance for Industry. 2013. www.fda.gov/regulatory-information/search-fda-guidance-documents/oversig..., FDA-2011-D-0597
    1. US Food and Drug Administration : FDA guidance on conduct of clinical trials of medical products during COVID-19 pandemic: Guidance for industry, investigators, and institutional review boards. 2020. www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-gui..., FDA-2020-D-1106-0002
    1. National Institutes of Health : Guidance for NIH-Funded Clinical Trials and Human Subjects Studies Affected by COVID-19. 2020. www.grants.nih.gov/grants/guide/notice-files/NOT-OD-20-087.html

Publication types